Contact number
+1 213 896 6000Provided by Sidley Austin LLP
Sidley’s California Life Sciences practice stands apart because we leverage our dominant global life sciences practice to offer California biotech and life sciences companies all the key practice areas that are relevant to their businesses. In addition, as California life sciences companies look to scale and launch their products internationally, they require a firm like Sidley that can provide a complete solution for all their legal needs, including regulatory and compliance.
Our practice occupies a unique space in the legal marketplace. Sidley is recognized as a leader in both regulatory and transactional work. This provides tangible benefit to our clients. We review and comment on client press releases, prospectuses and other SEC filings, and presentations from an integrated perspective reflecting securities law and regulatory comments. We are able to handle critical intellectual property licensing transactions and are involved in some of the most significant IP litigation. A global law firm with 20 offices around the world, Sidley can take on the most complex inter-jurisdictional life science matters. Sidley offers our clients a full-service approach to their issues from capital market transactions, to regulatory needs, to intellectual property challenges that may arise around the world. We are the firm that can serve our clients at all stages of the product life cycle as their needs expand in complexity and geographic scope.
Provided by Chambers
Sidley Austin LLP is well equipped to handle a diverse range of life sciences concerns, including acquisitions, collaborations and capital raising as well as intellectual property disputes and other litigation. The team brings to bear substantial regulatory bench strength and an international presence to advise clients in the biotech and pharmaceutical sectors.
Provided by Sidley Austin LLP
Sidley represented Akeso in a $5 billion cross-border collaboration and licensing agreement with Summit Therapeutics to out-license its bi-specific antibody, ivonescimab, for development and commercialisation in the US, Canada, Europe, and Japan.
Provided by Chambers
"The Sidley team can provide critical strategic guidance on complex and sophisticated matters. The attorneys have the depth of knowledge to successfully lead key transactions, and the bandwidth to meet all of our needs across practices areas."
"The Sidley team can provide critical strategic guidance on complex and sophisticated matters. The attorneys have the depth of knowledge to successfully lead key transactions, and the bandwidth to meet all of our needs across practices areas."
Provided by Chambers
Stephen Abreu regularly advises clients on high-value collaboration and licensing agreements. He has notable experience acting in matters with substantial cross-border elements.
Thomas Duley is a respected transactional attorney who offers noteworthy expertise on collaboration and licensing agreements within the life sciences space.
"Thomas immerses himself in the matter and ensures that our positions align with our strategic commercial goals."
"Thomas is extremely experienced and very smooth in negotiations. We highly value having him as a trusted partner."